Showing results (201-210 of 372) with videos related to
Sort By:
Pageof 38
Human Gene Therapy|October 6, 1998
Antitumor activity of bax and p53 naked gene transfer in lung cancer: in vitro and in vivo analysisJ L Coll, A Negoescu, N Louis, et al.Leukemia|May 10, 2000
Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4AM B Møller, P W Kania, Y Ino, et al.Acta Neuropathologica|July 1, 1997
Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expressionY Ono, T Tamiya, T Ichikawa, et al.Journal of Cutaneous Pathology|January 26, 2023
Atretic cephalocele and encephalocele: A single-institution clinicopathological studyMelanie Lang-Orsini, Samantha N Champion, Ann-Christine Duhaime, et al.Gene Therapy|July 15, 2003
Development of a novel non-human primate model for preclinical gene vector safety studies. Determining the effects of intracerebral HSV-1 inoculation in the common marmoset: a comparative studyT S Deisboeck, H Wakimoto, U Nestler, et al.Journal of Neuropathology and Experimental Neurology|June 1, 1997
Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous systemA O Stemmer-Rachamimov, C Gonzalez-Agosti, L Xu, et al.Acta Neuropathologica|July 10, 2007
The 2007 WHO classification of tumours of the central nervous systemDavid N Louis, Hiroko Ohgaki, Otmar D Wiestler, et al.Brain : a Journal of Neurology|December 1, 1993
Nucleolar organizer regions in optic gliomasM A Burnstine, L A Levin, D N Louis, et al.Neuro-Oncology|October 11, 2017
Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendationsJohn C DeWitt, Justin T Jordan, Matthew P Frosch, et al.Neurology|November 26, 2003
Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1D H Gutmann, C D James, M Poyhonen, et al.Pageof 38